One of the most frequently asked questions I receive is: "Do
I really need to be on insulin?" Well, if you have
Type 1 diabetes (click
here for a discussion on the differences between Type 1 and Type 2 diabetes)
then unless you take insulin you will not
survive. If you have Type 2 diabetes, insulin is usually reserved for the
situation wherein lifestyle measures (proper diet, exercise, getting to a good
weight, etc.) and oral
hypoglycemic agents are not sufficient to maintain adequate blood glucose
control. Regardless of which type of diabetes you have, the goal is to
have optimal sugar control because the better your sugars are, the lower is the
likelihood of progressive damage to your body (especially your eyes, your
kidneys and your nerve endings). If you are interested, you can refer to
the two landmark studies that confirmed this: the DCCT study for DM 1 & the UKPDS for DM 2.
Once the decision is made that insulin is necessary then it must
be decided which type of insulin is to be used and how often it is to be
given.
In tabular format the available insulins in Canada are:
| CLASS |
GENERIC NAME |
TRADE NAME |
| Rapid-acting |
aspart |
NovoRapid |
| lispro |
Humalog |
| Fast-acting |
regular* |
Humulin-R, Novolin ge Toronto |
| Intermediate-acting |
NPH |
Humulin-N, Novolin ge NPH |
| Long-acting |
glargine |
Lantus |
| detemir |
Levemir |
| Pre-mixed insulin |
These contain a mixture of either rapid-acting or
fast-acting insulin and intermediate acting insulin. These
include 30/70 (the most popular
one), Humalog Mix 25, Humalog Mix 50 and NovoMix30. |
(* Regular insulin is
referred to as 'Toronto' insulin everywhere in the world so long as your
world happens to be confined to a town of about two million people located
on the northwestern shore of Lake Ontario where insulin was first
discovered.)
The actions of these insulins
are shown on this graph (Apidra is not yet available in Canada):

(Adapted from NEJM, 352;2 and
other sources)
It is very important to know
that the properties noted above are averages and there can be quite a bit
of difference in how you respond to a type of insulin compared with how
someone else responds to that same insulin; heck, even for how you respond
on one occasion compared to another! See
here for more on insulin action variability).
For individuals with Type 1 diabetes
(and for many people with type 2 diabetes), far and away the
preferred insulin regimen is to be on "intensified" management. This
is usually best accomplished with a rapid-acting insulin (Humalog or
Novorapid) given with meals and a longer acting insulin (NPH
or Lantus or Levemir) given at bedtime. Some people will require the
longer acting insulin to be given twice a day (breakfast and bedtime).
Compared with regular insulin,
rapid-acting insulin has the advantage of being faster acting
and hence is given just as you are about to eat whereas regular insulin should
be given about 1/2 hour before you eat (though virtually no one does).
Additionally, rapid-acting insulin peaks quickly and leaves the body quickly so it helps to
bring the sugar level down faster after you eat. Also, since it leaves the
system quickly it makes insulin reactions less likely to occur several hours
after the insulin dose is given. And most (but not all) people on Humalog
or Novorapid
find it more flexible in terms of meal timing and dose adjustment based on
size/type of meals and exercise. Having said all that, if you are on
regular insulin with your meals and are doing just fine with that, then there is
no compelling reason to switch to Humalog or NovoRapid.
Lantus (glargine) and Levemir (detemir) are longer acting
insulins than NPH and tend to give more consistent control with fewer episodes
of hypoglycemia (especially overnight). I've used these newer insulins
with increasing frequency in my practice and to this point have been thrilled
with the results. One important caveat though: they are much more
expensive than NPH.
The following table illustrates the usual insulin schedule for
people on NPH & Humalog (or NovoRapid):
|
Type of insulin |
Breakfast |
Lunch |
Dinner |
Bedtime |
|
NPH* |
|
|
|
x |
|
Humalog/NovoRapid |
x |
x |
x |
|
* (An additional dose of NPH
insulin given in the morning is often necessary for people with type 1
diabetes.)
The following table illustrates the usual insulin schedule for
people on Lantus (or Levemir) & Humalog (or NovoRapid):
|
Type of insulin |
Breakfast |
Lunch |
Dinner |
Bedtime |
|
Lantus/Levemir* |
|
|
|
x |
|
Humalog/NovoRapid |
x |
x |
x |
|
*(Lantus is usually initiated
at bedtime, but for most people it works equally well if given at any
time of day...it's important, though, to be consistent day-to-day in
terms of when you give it. Also, whereas Lantus is almost always
given once a day, Levemir insulin is often needed twice a day if you
have type 1 diabetes.)
The following table illustrates the usual insulin schedule for people on
NPH & regular insulin:
|
Type of insulin |
Breakfast |
Lunch |
Dinner |
Bedtime |
|
NPH |
|
|
|
x |
|
regular |
x |
x |
x |
|
So what schedule should you be on? The answer is simple.
Whatever works best for you. Often this is determined only by trial
and error. I talk about how to adjust insulin on the
Frequently Asked Questions page.
The other choice available for
intensive insulin management is insulin pump therapy. I discuss this
option further here.
For individuals with Type 2 diabetes,
when insulin is needed it has typically been given as a pre-mixed combination of regular and NPH insulin
(generally in a ratio of 1/3 regular and 2/3 NPH) with a larger dose in the
morning and a smaller dose in the evening, however intensified insulin therapy
(described above) is gradually taking over as the preferred insulin strategy for
those people with type 2 diabetes who require insulin (due to its greater
flexibility and, often, its better ability to achieve target blood glucose
readings). As Type 2 diabetes is a
condition of insulin resistance, it is increasingly common to be on both insulin
(given to make up for the pancreas' shortfall in insulin production) and
oral hypoglycemic agents
(particularly metformin) to allow the
insulin to work more effectively. TZD drugs (egs., Avandia, Actos) also
work well in this circumstance, but are not "officially approved" (in
Canada anyhow) for this
indication and increase the risk of congestive heart failure; as such, if a TZD
and insulin are used together this needs to be done with great care.
Regardless of which insulin schedule is used, it is crucial to think of
starting insulin as just that - a start - with the dose
often intentionally an underestimate of what your requirements are likely to be
with the expectation being that frequent dose adjustment will be necessary (done
under the close supervision of a physician and/or a diabetes nurse educator)
until target readings are reached. Simply put, it is safer to under-dose
someone with insulin than to over-dose them. A motto a wise doctor follows
when starting a patient on insulin: "start low & go slow." (Though, I
should add, not too slow!). You might wish to have a look at a copy
of a letter I give out to my patients who
are being started on insulin.